Article
Fairholme Sticks to Quality Names (RealMoney.com $)
It's time for my quarterly Fairholme check-in, which reveals some intriguing ideas.
03:55PM 11/17/09
Article
Watching Klarman's Latest Biotech Play (RealMoney.com $)
Baupost's investment in Enzon is a essentially a purchase of future royalty streams.
03:15PM 11/12/09


RSS Feed
Connect with TheStreet